Pharmacological Intervention through Dietary Nutraceuticals in Gastrointestinal Neoplasia

Critical Reviews in Food Science and Nutrition

Volumn 56, Issue 9, 2016, Pages 1501-1518

  Ullah, Mohammad F ^a   Bhat, Showket H ^a   Husain, Eram ^a   Abu Duhier, Faisel ^a   Hadi, S M ^b   Sarkar, Fazlul H ^c   Ahmad, Aamir ^c  

^a UNIVERSITY OF TABUK   (Saudi Arabia)

^b ALIGARH MUSLIM UNIVERSITY   (India)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aberrant cryptic foci; chemoprevention; clinical trials; colon cancer; curcumin; epigallocatechin 3 gallate; gamma amino butyric acid; Gastric neoplasm; lycopene; nutraceutical; pharmacological intervention; resveratrol

Indexed keywords

BUTYRIC ACID; FLAVONOIDS; METABOLITES; PATHOLOGY; RESVERATROL;

ABERRANT CRYPTIC FOCI; CHEMOPREVENTION; CLINICAL TRIAL; COLON CANCER; CURCUMIN; EPIGALLOCATECHIN-3-GALLATE; GASTRIC NEOPLASMS; LYCOPENES; NUTRACEUTICALS; PHARMACOLOGICAL INTERVENTION;

DISEASES;

ANTINEOPLASTIC AGENT; CAROTENOID; CURCUMIN; ISOFLAVONE DERIVATIVE; STILBENE DERIVATIVE;

ANIMAL; DIET; DIETARY SUPPLEMENT; GASTROINTESTINAL NEOPLASMS; HUMAN;

ANIMALS; ANTICARCINOGENIC AGENTS; CAROTENOIDS; CURCUMIN; DIET; DIETARY SUPPLEMENTS; GASTROINTESTINAL NEOPLASMS; HUMANS; ISOFLAVONES; STILBENES;

EID: 84975167805     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2013.772091     Document Type: Review

References (194)

1. V.M.Adhami, N.Khan, and H.Mukhtar,. (2009). Cancer chemoprevention by pomegranate: Laboratory and clinical evidence. Nutr Cancer. 61:811–815.
2. V.M.Adhami, and H.Mukhtar,. (2013). Human cancer chemoprevention: Hurdles and challenges. Top. Curr. Chem. 329:203–220.
3. H.Adlercreutz,. (1998). Epidemiology of phytoestrogens. Baillieres Clin. Endocrinol. Metab. 12:605–623.
4. H.Adlercreutz,. (2002). Phytoestrogens and cancer. Lancet Oncology. 3:364–373.
5. T.Akimoto, T.Nonaka, H.Ishikawa, et al. (2001). Genistein, a tyrosine kinase inhibitor, enhancedradiosensitivity in human esophageal cancer cell lines in vitro: Possible involvement of inhibition of survival signal transduction pathways. Int. J. Radiat. Oncol. Biol. Phys. 50:195–201.
6. T.Akiyama, J.Ishida, S.Nakagawa, et al. (1987). Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592–5595.
7. S.Ali, A.Ahmad, S.Banerjee, et al. (2010). Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res. 70:3606–3617.
8. H.A.N.Al-Wadei, H.K.Plummer, H.M.Schuller, et al. (2009). Nicotine stimulates pancreatic cancer xenografts by systemic increase in stress neurotransmitters and suppression of the inhibitory neurotransmitter γ-aminobutyric acid. Carcinogenesis. 30:506–511.
9. H.A.N.Al-Wadei, M.F.Ullah, and M.Al-Wadei,. (2011). GABA (gamma-aminobutyric acid), a non-protein amino acid counters the β-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: A review of experimental evidence. Mol. Nutr. Food Res. 55:1745–1758.
10. American Cancer Society. (2012). Cancer Facts & Figures 2012. American Cancer Society, Atlanta.
11. American Society for Gastrointestinal Endoscopy. (2006). Understanding Polyps and Their Treatment [Online]. Available: http://www.asge.org/nspages/practice/management/brochures/polyps_brochure.cfm.
12. P.Anand, A.B.Kunnumakkara, R.A.Newman, and B.B.Aggarwal,. (2007). Bioavailability of curcumin: Problems and promises. Mol. Pharmacol. 4:807–818.
13. I.C.Arts, D.R.Jacobs, Jr., et al. (2002a). Dietary catechins and cancer incidence: The Iowa Women's Health Study. IARC Sci. Publ. 156:353–355.
14. I.C.Arts, D.R.Jacobs, Jr, M.Gross, et al. (2002b). Dietary catechins and cancer incidence among postmenopausal women: The Iowa Women's Health Study (United States). Cancer Causes Control. 13:373–382.
15. M.A.Azuine, and S.V.Bhide,. (1992). Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer. 17:77–83.
16. Y.Baba, J.I.Sonoda, S.Hayashi, et al. (2012). Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp. Ther. Med. 4:452–458.
17. F.Balkwill, K.A.Charles, and A.Mantovani,. (2005). Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 7:211–217.
18. E.Benito, A.Obrador, A.Stiggelbout, et al. (1990). A population-based case-control study of colorectal cancer in Majorca: Dietary factors. Int. J. Cancer. 45:69–76.
19. V.Bhuvaneswari, B.Velmurugan, and S.Nagini,. (2001). Lycopene, an antioxidant carotenoid modulates glutathione-dependent hepatic biotransformation enzymes during experimental gastric carcinogenesis. Nutr. Res. 8:1117–1124.
20. F.Borrelli, R.Capasso, A.Russo, et al. (2004). Systematic review: Green tea and gastrointestinal cancer risk. Ailment Pharmacol. Ther. 19:497–510.
21. V.Brower,. (1998). Nutraceuticals: Poised for a healthy slice of the healthcare market? Nat. Biotechnol. 16:728–731.
22. P.G.J.Burney, G.W.Constock, and J.S.Morris,. (1989). Serologic precursors of cancer: Serum micronutrients and the subsequent risk of pancreatic cancer. Am. J. Clin. Nutr. 49:895–900.
23. R.E.Carroll, R.V.Benya, D.K.Turgeon, et al. (2011). Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev. Res. (Phila). 4:354–364.
24. R.E.Carroll, R.A.Goodlad, A.J.Poole, et al. (2009). Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats. Growth Horm. IGF Res. 19:447–456.
25. D.P.Chauhan,. (2002). Chemotherapeutic potential of curcumin for colorectal cancer. Curr. Pharm. Des. 8:1695–1706.
26. Z.Chen, Q.Chen, H.Xia, et al. (2011). Green tea drinking habits and esophageal cancer in southern China: A case-control study. Asian Pac. J. Cancer Prev. 12:229–233.
27. A.L.Cheng, C.H.Hsu, J.K.Lin, et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21:2895–2900.
28. H.H.Chow, I.A.Hakim, D.R.Vining, et al. (2005). Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res. 11:4627–4633.
29. S.K.Clinton,. (1998). Lycopene: Chemistry, Biology, and Implications for Human Health and Disease. Nutr. Rev. 56:35–51.
30. P.J.Cook-Mozaffari, F.Azordegan, N.E.Day, et al. (1979). Oesophageal cancer studies in the Caspian Littoral of Iran: Results of a case-control study. Br. J. Cancer. 39:293–309.
31. P.Correa,. (1992). Human gastric carcinogenesis: A multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 52:6735–6740.
32. M.Cruz-Correa, D.A.Shoskes, P.Sanchez, et al. (2006). Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin. Gastroenterol. Hepatol. 4:1035–1038.
33. C.D.Davis, and J.A.Milner,. (2009). Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem. 20:743–752.
34. R.De, P.Kundu, S.Swarnakar, et al. (2009). Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 53:1592–1597.
35. R.Deewatthanawong, F.Jacqueline, and C.B.Watkins,. (2010). Gamma-aminobutyric acid (GABA) accumulation in four strawberry cultivars in response to elevated CO2 storage. Postharvest Biol. Technol. 57:92–96.
36. N.Dhillon, B.B.Aggarwal, R.A.Newman, et al. (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14:449–449.
37. H.Ding, Y.W.Chin, A.D.Kinghorn, and S.M.D.Ambrosio,. (2007). Chemopreventive characteristics of avocado fruit. Sem. Cancer Biol. 17:386–394.
38. I.Dora, L.Arab, A.Martinchik, et al. (2003). Black tea consumption and risk of rectal cancer in Moscow population. Ann. Epidemiol. 13:405–411.
39. J.G.Erhardt, C.Meisner, and J.C.Bode,. (2003). Lycopene, beta-carotene, and colorectal adenomas. Am. J. Clin. Nutr. 78:1219–1224.
40. Y.Z.Fan, G.H.Li, Y.H.Wang, et al. (2010). Effects of genistein on colon cancer cells in vitro and in vivo and its mechanism of action. Zhonghua Zhong Liu Za Zhi. 32:4–9.
41. A.Fichera, N.Little, S.Jagadeeswaran, et al. (2007). Epidermal growth factorreceptor signaling is required for micro adenoma formation in the mouseazoxymethane model of colonic carcinogenesis. Cancer Res. 15:827–835.
42. S.Franceschi, E.Bidoli, C.La, Veccia, et al. (1994). Tomatoes and risk of digestive-tract cancers. Int. J. Cancer. 59:181–184.
43. M.Franek,. (2004). History and the present of metabotropic GABAB receptor. Cesk Fysiol. 53:117–124.
44. L.Fuccio, R.M.Zagari, L.H.Eusebi, et al. (2009). Meta-analysis: Can Helicobacter Pylori eradication treatment reduce the risk for gastric cancer? Ann. Intern. Med. 21:121–128.
45. H.Fujiki, K.Imai, K.Nakachi, et al. (2012). Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J. Cancer Res. Clin. Oncol. 138:1259–1270.
46. Y.T.Gao, J.K.McLaughlin, W.J.Blot, et al. (1994). Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86:855–858.
47. G.Garcea, D.P.Berry, and D.J.Jones,. (2005). Consumption of the putative chemopreventive Agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol. Biomarkers Prev. 14:120–125.
48. H.Gerster,. (1997). The potential role of lycopene for human health. J. Am. Coll. Nutr. 16:109–126.
49. P.Ghadirian,. (1987). Thermal irritation and esophageal cancer in northern Iran. Cancer. 60:1909–1914.
50. E.Giovannucci,. (1999). Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic Literature. J. Natl. Cancer Inst. 91:317–331.
51. V.Gordon, and J.Jankowski,. (2011). Chemoprevention in Barrett's oesophagus. Best Pract. Res. Clin. Gastroenterol. 25:569–579.
52. A.Gupte, and R.J.Mumper,. (2009). Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat. Rev. 35:32–46.
53. H.Hagiwara, T.Seki, and T.Ariga,. (2004). The effect of pre-germinated brown rice intake on blood glucose and PAI-1 levels in streptozotocin-induced diabetic rats. Biosci. Biotechnol. Biochem. 68:444–447.
54. I.A.Hakim, V.Hartz, R.B.Harris, et al. (2001). Reproducibility and relative validity of a questionnaire to assess intake of black tea polyphenols in epidemiological studies. Cancer Epidemiol. Biomarkers Prev. 10:667–678.
55. K.Hayakawa, M.Kimura, K.Kasaha, et al. (2004). Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br. J. Nutr. 92:411–417.
56. M.T.Huang, Y.R.Lou, W.Ma, H.L.Newmark, K.R.Reuhl, and A.H.Conney,. (1994). Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54:5841–5847.
57. A.C.Huderson, J.N.Myers, M.S.Niaz, M.K.Washington, and A.Ramesh,. (2012). Chemoprevention of benzo(a)pyrene-induced colon polyps in Apc(Min) mice by resveratrol. J. Nutr. Biochem. [Epub ahead of print].
58. T.Hunter,. (1984). The proteins of oncogenes. Sci. Am. 251:70–79.
59. J.T.Hwang, J.Ha, and O.J.Park,. (2005). Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2signa ling pathways. Biochem. Biophys. Res. Commun. 332:433–440.
60. M.Inoue, K.Tajima, K.Hirose, et al. (1998). Tea and coffee consumption and the risk of digestive tract cancers: Data from a comparative case-referent study in Japan. Cancer Causes Control. 9:209–216.
61. M.Jang, L.Cai, G.O.Udeani, et al. (1997). Cancer chemopreventive activity of Resveratrol, a natural product derived from grapes. Science. 275:218–220.
62. A.Jatoi, N.Ellison, P.A.Burch, et al. (2003). A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 97:1442–1446.
63. A.Jemal, R.Siegel, J.Xu, and E.Ward,. (2010). Cancer statistics, 2010. CA Cancer J. Clin. 60:277–300.
64. B.T.Ji, W.H.Chow, A.W.Hsing, et al. (1997). Green tea consumption and the risk of pancreatic and colorectal cancers. Int. J. Cancer. 70:255–258.
65. C.Y.Jin, C.Park, J.H.Cheong, et al. (2007). Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3. Cancer Lett. 257:56–64.
66. J.J.Johnson, M.Nihal, I.A.Siddiqui, et al. (2011). Enhancing the bioavailability of resveratrol by combining it with piperine. Mol. Nutr. Food Res. 55:1169–1176.
67. J.Joseph, B.Niggemann, K.S.Zaenker, et al. (2002). The neurotransmitter gamma aminobutyric acid is an inhibitory regulator for the migration of SW480 colon carcinoma cells. Cancer Res. 62:6467–6469.
68. J.Ju, J.Hong, J.N.Zhou, Z.Pan, M.Bose, J.Liao, et al. (2005). Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65:10623–10631.
69. J.Ju, Y.Liu, J.Hong, et al. (2003). Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model. Nutr Cancer. 46:172–178.
70. J.Ju, G.Lu, J.D.Lambert, and C.S.Yang,. (2007). Inhibition of carcinogenesis by tea constituents. Sem. Cancer Biol. 17:395–402.
71. M.Kanai, K.Yoshimura, M.Asada, et al. (2011). A phase I/II study of gemcitabine based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother. Pharmacol. 68:157–164.
72. K.Kawabata, T.Tanaka, and T.Murakami,. (1999). Dietary prevention of azoxymethane induced colon carcinogenesis with rice germ in F344 rats. Carcinogenesis. 20:2107–2115.
73. N.Khan, F.Afaq, and H.Mukhtar,. (2010). Lifestyle as risk factor for cancer: Evidence from human studies. Cancer Lett. 293:133–143.
74. N.Khan, and H.Mukhtar,. (2007). Tea polyphenols for health promotion. Life Sci. 81:519–533.
75. N.Khan, and H.Mukhtar,. (2008). Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett. 269:269–280.
76. N.Khan, and H.Mukhtar,. (2010). Cancer and metastasis: Prevention and treatment by green tea. Cancer Metastasis Rev. 29:435–445.
77. J.Khatiwada, M.Verghese, S.Davis, et al. (2011). Green tea, phytic acid, and inositol in combination reduced the incidence of azoxymethane-induced colon tumors in Fisher 344 male rats. J. Med Food. 14:1313–1330.
78. S.O.Kim, and W.K.Choe,. (2011). Effect of EGCG on expression of neurogenin 3 via the MAP kinase signaling pathway in AR42J Cells, a rat pancreatic tumor cell line. Korean J. Nutr. 44:196–202.
79. M.J.Kim, G.R.Ryu, J.S.Chung, et al. (2003). Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: In vivo and in vitro. Pancreas. 26:292–299.
80. E.J.Kim, H.K.Shin, and J.H.Park,. (2005). Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: A possible mechanism of the growth inhibitory effect of genistein. J. Med Food. 8:431–438.
81. A.M.Kinnersley, and F.J.Turano,. (2000). γ-Aminobutyric acid (GABA) and plant responses to stress. Crit Rev. Plant Sci. 19:479–509.
82. N.B.Kumar, K.Besterman-Dahan, L.Kang, et al. (2008). Results of a randomized clinical trial of the action of several doses of lycopene in localized prostate cancer: Administration prior to radical prostatectomy. Clin. Med. Urol. 1:1–4.
83. A.B.Kunnumakkara, S.Guha, S.Krishnan, P.Diagaradjane, J.Gelovani, and B.B.Aggarwal,. (2007). Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 67:3853–3861.
84. J.D.Lambert, J.Hong, G.Y.Yang, et al. (2005). Inhibition of carcinogenesis by polyphenols: Evidence from laboratory investigations. Am. J. Clin. Nutr. 81:284S–291S.
85. S.A.Laurie, V.A.Miller, S.C.Grant, et al. (2005). Phase I study of green tea extract in patients with advanced lung cancer. Cancer Chemother. Pharmacol. 55:33–38.
86. M.J.Lee, P.Maliakal, L.Chen, et al. (2002) Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev. 11:1025–1032.
87. R.J.Lefkowitz, B.B.Hoffman, P.Taylor,. (1990). In: The Pharmacological Basis of Therapeutics, 8th ed., pp. 84–121, G.A.Goodman, T.W.Rall, A.S.Niel, P.Taylor,., Eds., Pergamon Press, New York, 1990.
88. Z.G.Li, Y.Shimada, F.Sato, et al. (2002). Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats. Int. J. Oncol. 21:1275–1283.
89. Y.S.Li, L.P.Wu, K.H.Li, et al. (2011). Involvement of Nuclear Factor κB (NF-κB) in the Downregulation of Cyclooxygenase-2 (COX-2) by Genistein in Gastric Cancer Cells. J. Int. Med. Res. 39:2141–2150.
90. J.K.Lin, Y.C.Liang, and S.Y.Lin-Shiau,. (1999). Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 58:911–915.
91. M.L.Lin, Y.C.Lu, H.Y.Chen, C.C.Lee, J.G.Chung, and S.S.Chen,. (2012). Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by Curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells. Mol. Carcinogenesis [Epub ahead of print].
92. Y.S.Liu, and X.M.Li,. (2011). Genistein Induced Apotosis in Human Gastric Carcinoma Cells. Adv. Mat. Res. 185:1283–1286.
93. B.D.Lyn-Cook, T.Rogers, Y.Yan, et al. (1999). Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr. Cancer. 35:80–86.
94. G.Macquart-Moulin, E.Riboli, J.Cornee, et al. (1986). Case control study of colorectal cancer and diet in Marseilles. Int. J. Cancer. 38:183–191.
95. P.Maliakal, U.T.Sankpal, R.Basha, et al. (2011). Relevance of drug metabolizing enzyme activity modulation by tea polyphenols in the inhibition of esophageal tumorigenesis. Med. Chem. 7:480–487.
96. A.R.Mangels, J.M.Holden, G.R.Beecher, et al. (1993). Carotenoid content of fruits and vegetables: an evaluation of analytic data. J. Am. Diet. Assoc. 93:284–296.
97. R.Manikandan, M.Beulaja, C.Arulvasu, et al. (2012). Synergistic anticancer activity of curcumin and catechin: an in vitro study using human cancer cell lines. Micros. Res. Tech. 75:112–116.
98. B.Marchetti, P.G.Spinola, G.Pelletier, and F.Labrie,. (1991). A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: Hormonal control of beta-adrenergic receptors and correlation with tumor growth. J. Steroid Biochem. Mol. Biol. 38:307–320.
99. K.Masur, B.Niggemann, K.S.Zanker, et al. (2001). Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res. 61:2866–2869.
100. D.L.McKay, and J.B.Blumberg,. (2002). The role of tea in human health: An update. J. Am. Coll. Nutr. 21:1–13.
101. K.B.Michels, W.C.Willett, C.S.Fuchs, et al. (2005). Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J. Natl. Cancer Inst. 97:282–292.
102. P.Mitruţ, F.L.Burada, A.Enescu, et al. (2009). The genotoxicity study of resveratrol in primary gastric adenocarcinoma cell cultures. Rom. J. Morphol. Embryol. 50:429–433.
103. B.Modan, H.Cuckle, and F.Lubin,. (1981). A note on the role of dietary retinol and carotene in human gastrointestinal cancer. Int. J. Cancer. 28:421–424.
104. L.N.Mu, Q.Y.Lu, S.Z.Yu, et al. (2005). Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int. J. Cancer. 116:972–983.
105. H.Mukhtar,. (2012). Chemoprevention: Making it a success story for controlling human cancer. Cancer Lett. 326:123–127.
106. E.Mukhtar, V.M.Adhami, N.Khan, and H.Mukhtar,. (2012). Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents. Curr. Drug Targets. 13:1831–1841.
107. T.Narisawa, Y.Fukaura, M.Hasebe, et al. (1996). Inhibitory effects of natural carotenoids, a-carotene, beta-carotene, lycopeneand lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett. 107:137–142.
108. S.Nechuta, X.O.Shu, H.L.Li, et al. (2012). Prospective cohort study of tea consumption and risk of digestive system cancers: Results from the Shanghai Women's Health Study. Am. J. Clin. Nutr. 96:1056–1063.
109. A.V.Nguyen, M.Martinez, M.J.Stamos, et al. (2009). Results of a phase I pilot clinicaltrial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manage. Res. 1:25–37.
110. A.M.Nomura, R.G.Ziegler, G.N.Stemmermann, et al. (1997). Serum micronutrients and upper digestive tract cancer. Cancer Epidemiol. Biomarkers Prev. 6:407–412.
111. M.Nouraie, P.Pietinen, F.Kamangar, et al. (2005). Fruits, Vegetables, and Antioxidants and Risk of Gastric Cancer among Male Smokers. Cancer Epidemiol. Biomarkers Prev. 14:2087–2092.
112. M.Ogasawara, T.Matsunaga, and H.Suzuki,. (2007). Differential effects of antioxidants on the in vitro invasion, growth and lung metastasis of murine colon cancer cells. Biol. Pharm. Bull. 30:200–204.
113. K.Ogawa, T.Hara, M.Shimizu, et al. (2012). Suppression of azoxymethaneinduced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase. Cancer Sci. 103:951–958.
114. S.H.Oh, and C.H.Oh,. (2003). Brown rice extracts with enhanced levels of GABA stimulate immune cells. Food Sci. Biotechnol. 12:248–252.
115. E.J.Okello, G.J.McDougall, S.Kumar, et al. (2011). In vitro protective effects of colon-available extract of Camellia sinensis (tea) against hydrogen peroxide and beta-amyloid (Aβ((1–42))) induced cytotoxicity in differentiated PC12 cells. Phytomedicine. 18:691–696.
116. K.Okushio, N.Matsumoto, T.Kohri, et al. (1996). Absorption of tea catechins into rat portal vein. Biol. Pharm. Bull. 19:326–329.
117. C.Onoda, K.Kuribayashi, S.Nirasawa, et al. (2011). (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int. J. Oncol. 38:1403–1408.
118. J.Park, and C.N.Conteas,. (2010). Anti-carcinogenic properties of curcumin on colorectal cancer. World J. Gastrointest. Oncol. 15:169–176.
119. K.R.Patel, V.A.Brown, D.J.Jones, et al. (2010). Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70:7392–7399.
120. K.M.Pisters, R.A.Newman, B.Coldman, et al. (2001). Phase I trial of oral green tea extract in adult patients with solid tumors. J. Clin. Oncol. 19:1830–1838.
121. E.A.Platz, W.C.Willett, G.A.Colditz, E.B.Rimm, D.Spiegelman, and E.Giovannucci,. (2000). Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control. 11:579–588.
122. S.Qanungo, M.Das, S.Haldar, et al. (2005). Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis. 26:958–967.
123. W.Qi, C.R.Weber, K.Wasland, et al. (2011). Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer. 20;211–219.
124. A.Ramadas, and M.Kandiah,. (2009), Food intake and colorectal adenomas: A Case-Control Study in Malaysia. Asian Pac. J. Cancer Prev. 10:925–932.
125. A.V.Rao, and S.Aggarwal,. (1999). Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: A review. Nutr. Res. 19:305–323.
126. R.L.Rego, N.R.Foster, T.C.Smyrk, et al. (2010). Prognostic effect of activated EGFR expression in human colon carcinomas: Comparison with EGFR status. Br. J. Cancer. 102:165–172.
127. A.B.Ross, L.T.Vuong, J.Ruckle, et al. (2011). Lycopene bioavailability and metabolism in humans: An accelerator mass spectrometry study. Am. J. Clin. Nutr. 93:1263–1273.
128. N.A.Sadik,. (2012). Chemopreventive efficacy of green tea drinking against 1,2- dimethyl hydrazine-induced rat colon carcinogenesis. Cell Biochem. Funct. 31:196–207.
129. T.Saito, C.Matsukura, M.Sugiyama, A.Watahiki, et al. (2008). Screening for gamma-aminobutyric acid (GABA)-rich tomato varieties. J. Jpn Soc. Hortic. Sci. 77:242–250.
130. G.I.Salti, S.Grewal, R.R.Mehta, et al. (2000). Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur. J. Cancer. 36:796–802.
131. M.J.Sanderson, K.L.White, I.M.Drake, et al. (1997). Vitamin E and carotenoids in gastric biopsies: The relation to plasma concentrations in patients with and without Helicobacter pylori gastritis. Am. J. Clin. Nutr. 65:101–106.
132. S.Sasazuki, A.Tamakoshi, K.Matsuo, et al. (2012). Green tea consumption and gastric cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J. Clin. Oncol. 42:335–346.
133. B.Schleipen, T.Hertrampf, K.H.Fritzemeier, et al. (2011). ERβ-specific agonists and genistein inhibit proliferation and induce apoptosis in the large and small intestine. Carcinogenesis. 32:1675–1683.
134. Y.Schneider, B.Duranton, F.Gossé, R.Schleiffer, N.Seiler, and F.Raul,. (2001). Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr. Cancer. 39:102–107.
135. H.M.Schuller, H.A.Al-Wadei, M.Majidi, et al. (2008). GABA(B) receptor is a novel drug target for pancreatic cancer. Cancer. 112:767–778.
136. K.J.Scott, and D.J.Hart,. (1995). Development and evaluation of an HPLC method for the analysis of carotenoids in foods, and the measurement of the carotenoid content of vegetables and fruits commonly consumed in the UK. Food Chem. 54:101–111.
137. M.Sengottuvelan, and N.Nalini,. (2006). Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br. J. Nutr. 96:145–153.
138. M.Sengottuvelan, P.Viswanathan, and N.Nalini,. (2006). Chemopreventive effect of transresveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis. 27:1038–1046.
139. V.W.Setiawan, Z.F.Zhang, G.P.Yu, et al. (2001). Protective effect of green tea on the risks of chronic gastritis and stomach cancer. Int. J. Cancer. 92:600–604.
140. T.D.Shanafelt, T.G.Call, C.S.Zent, et al. (2013). Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer. 119:363–370.
141. R.A.Sharma, H.R.McLelland, K.A.Hill, et al. (2001). Pharmocodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 7:1894–1900.
142. A.Shibata, T.M.Mack, A.Paganini-Hill, et al. (1994). A prospective study of pancreatic cancer in the elderly. Int. J. Cancer. 58:46–49.
143. V.Y.Shin, H.C.Jin, and K.O.Enders,. (2008). Nicotine and 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and β-adrenergic receptor signaling pathways. Toxicol. Appl. Pharmacol. 233:254–261.
144. V.Y.Shin, W.K.Wu, K.M.Chu, et al. (2007). Functional role of beta-adrenergic receptors in the mitogenic action of nicotine on gastric cancer cells. Toxicol. Sci. 96:21–29.
145. I.A.Siddiqui, V.M.Adhami, N.Ahmad, and H.Mukhtar,. (2010). Nanochemoprevention: Sustained release of bioactive food components for cancer prevention. Nutr. Cancer. 62:883–890.
146. I.A.Siddiqui, and H.Mukhtar,. (2010). Nanochemoprevention by bioactive food components: A perspective. Pharm. Res. 27:1054–1060.
147. S.V.Singh, X.Hu, S.K.Srivastava, et al. (1998). Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis. 19:1357–1360.
148. B.N.Singh, S.Shankar, and R.K.Srivastava,. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 82:1807–1821.
149. S.Song, K.Krishnan, K.Liu, et al. (2009). Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression. Clin. Cancer Res. 15:622–631.
150. M.B.Sporn, and N.Suh,. (2002). Chemoprevention: An essential approach to controlling cancer. Nat. Rev. Cancer. 2:537–543.
151. G.D.Stoner, L.S.Wang, N.Zikri, et al. (2007). Cancer prevention with freeze-dried berries and berry components. Sem. Cancer Biol. 17:403–410.
152. L.J.Su, and L.Arab,. (2002). Tea consumption and the reduced risk of colon cancer – results from a national prospective cohort study. Publ. Health Nutr. 5:419–425.
153. D.Subramaniam, S.Ponnurangam, P.Ramamoorthy, et al. (2012). Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PLoS One. 7:e30590.
154. Y.J.Surh,. (2003). Cancer chemoprevention with dietary phytochemical. Nat. Rev. Cancer. 3:768–780.
155. M.V.Swamy, B.Citineni, J.M.Patlolla, A.Mohammed, Y.Zhang, and C.V.Rao,. (2008). Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr. Cancer. 60:81–89.
156. D.N.Syed, F.Afaq, and H.Mukhtar,. (2007). Pomegranate derived products for cancer chemoprevention. Sem. Cancer Biol. 17:377–385.
157. M.Tan, A.Norwood, M.May, et al. (2006). Effects of (-) epigallocatechingallate and thymoquinone on proliferation of a PANC-1 cell line in culture. Biomed. Sci. Instrum. 42:363–371.
158. T.Tanaka, T.Ishii, D.Mizuno, et al. (2011). (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68. Free Rad. Biol. Med. 50:1324–1335.
159. F.Y.Tang, H.J.Cho, M.H.Pai, and Y.H.Chen,. (2009). Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J. Nutr. Biochem. 20:426–434.
160. F.Y.Tang, M.H.Pai, and X.D.Wang,. (2011). Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model. J. Agric. Food Chem. 59:9011–9021.
161. F.Y.Tang, C.J.Shih, L.H.Cheng, et al. (2008). Lycopene inhibits growth of human colon cancer cells via suppression of the Akt signaling pathway. Mol. Nutr. Food Res. 52:646–654.
162. M.Tatsuta, H.Iishi, M.Baba, et al. (1990). Inhibition by γ-amino-n-butyric acid and baclofen of gastric carcinogenesis induced by N-Methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res. 50:4931–4934.
163. R.F.Tayyem, D.D.Heath, W.K.Al-Delaimy, and C.L.Rock,. (2006). Curcumin content of turmeric and curry powders. Nutr. Cancer. 55:126–131.
164. A.J.Teodoro, F.L.Oliveira, N.B.Martins, et al. (2012). Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int. 12:36–42.
165. L.Tessitore, A.Davit, I.Sarotto, and G.Caderni,. (2000). Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis. 21:1619–1622.
166. P.Thomas, H.Hayashi, R.Zimmer, et al. (2004). Regulation of cytokine production in carcinoembryonic antigen stimulated Kupffer cells by β-2 adrenergic receptors: Implications for hepatic metastasis. Cancer Lett. 209:251–257.
167. S.Tsugane, M.Tsuda, F.Gey, and S.Watanabe,. (1992). Cross-sectional study with multiple measurements of biological markers for assessing stomach cancer risks at the population level. Environ. Health Perspect. 98:207–210.
168. M.Unakami, M.Hara, S.Fukuchi, and H.Akiyama,. (1989). Cancer of the gastric cardia and the habit of smoking. Acta Pathol. Jpn. 39:420–424.
169. J.Ushida, S.Sugie, K.Kawabata, et al. (2000). Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn J. Cancer Res. 91:893–898.
170. H.Vainio, and E.Weiderpress,. (2006). Fruit and vegetables in cancer prevention. Nutr Cancer. 54:111–142.
171. S.Valcic, B.N.Timmermann, D.S.Alberts, et al. (1996). Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs. 7:461–468.
172. S.K.Vareed, M.Kakarala, M.T.Ruffin, et al. (2008). Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol. Biomarkers Prev. 17:1411–1417.
173. B.Velmurugan, A.Mani, and S.Nagini,. (2005). Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis. Eur. J. Cancer Prev. 14:387–293.
174. Z.Wang, A.Ahmad, S.Banerjee, et al. (2010). Foxm1 is a novel target of a natural agent in pancreatic cancer. Pharm. Res. 27:1159–1168.
175. H.F.Wang, Y.S.Tsai, M.L.Lin, et al. (2006). Comparison of bioactive components in GABA tea and green tea produced in Taiwan. Food Chem. 96:648–653.
176. Z.Y.Wang, L.D.Wang, M.J.Lee, et al. (1995). Inhibition of nitrosomethylbenzylamine-induced esophageal tumorigenesis in rats by green and black tea. Carcinogenesis. 16:2143–2148.
177. J.Wang, W.Zhang, L.Sun, et al. (2012). Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol. 36:e354–358.
178. K.Wertz, U.Siler, and R.Goralczyk,. (2004). Lycopene: Modes of action to promote prostate health. Arch. Biochem. Biophys. 430:127–134.
179. A.S.Whittemore, R.S.Paffenbarger, Jr, K.Anderson, et al. (1983). Early precursors of pancreatic cancer in college men. J. Chronic Dis. 36:251–256.
180. World Health Organization. (2011). Cancer fact sheet. February 2011. http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Accessed March30, 2011.
181. W.K.Wu, H.P.Wong, S.W.Luo, K.Chan, et al. (2005). 4-(Methylnitrosamino)-1-(3- pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoreceptors. Cancer Res. 65:5272–5277.
182. H.L.Xiang, F.Liu, M.F.Quan, et al. (2012). 7-difluoromethoxyl-5,4′-dinoctylgenistein inhibits growth of gastric cancer cells through donregulating forkhead box M1. World J. Gastroenterol. 18:4618–4626.
183. G.Yang, W.Zheng, Y.B.Xiang, et al. (2011). Green tea consumption and colorectal cancer risk: A report from the Shanghai Men's Health Study. Carcinogenesis. 32:1684–1688.
184. G.P.Yu, C.C.Hsieh, L.Y.Wang, et al. (1995). Green-tea consumption and risk of stomach cancer: A population-based case-control study in Shanghai, China. Cancer Causes Control. 6:532–538.
185. L.L.Yu, J.G.Wu, N.Dai, H.G.Yu, and J.M.Si,. (2011). Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor. Oncol. Rep. 26:1197–1203.
186. J.M.Yuan, C.Sun, and L.M.Butler,. (2011). Tea and cancer prevention: Epidemiological studies. Pharmacol. Res. 64:123–135.
187. W.A.Zatonski, P.Boyle, K.Przewozniak, et al. (1993). Cigarette smoking, alcohol, tea and coffee consumption and pancreas cancer risk: A case-control study from Opole, Poland. Int. J. Cancer. 53:601–607.
188. Y.Zhang, and H.Chen,. (2011). Genistein attenuates WNT signaling by upregulating sFRP2 in a human colon cancer cell line. Exp. Biol. Med. 236:714–722.
189. T.Zheng, P.Boyle, W.C.Willett, et al. (1993). A case–control study of oral cancer in Beijing, People's Republic of China. Associations with nutrient intakes, foods and food groups. Eur. J. Cancer B Oral Oncol. 29B:45–55.
190. W.Zheng, W.H.Chow, G.Yang, et al. (2005). The Shangai Women's health Study: Rationale, study design and base line characteristics. Am. J. Epidemiol. 162:1123–1131.
191. H.B.Zhou, J.M.Chen, J.T.Cai, et al. (2008). Anticancer activity of genistein on implanted tumor of human SG7901 cells in nude mice. World J. Gastroenterol. 14:627–631.
192. H.B.Zhou, J.J.Chen, W.X.Wang, et al. (2004). Apoptosis of human primary gastric carcinoma cells induced by genistein. World J. Gastroenterol. 10:1822–1825.
193. F.Zhou, H.Zhou, T.Wang, et al. (2012). Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro. Acta Pharmacol. Sinica. 33:120–126.
194. K.Zushi, and N.Matsuzoe, (2007). Salt stress-enhanced gamma-aminobutyric acid (GABA) in tomato fruit. Acta Hortic. 761:431–435.